Head-to-head · Cost-Efficiency Index
Bayan Health vs NexLife
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Bayan Health
Cost-first shoppers who want a flat all-dose price across several routes and can commit to a two- or three-month protocol.
Visit Bayan HealthNexLife
Cost-first shoppers who want wanting a genuinely flat, dose-independent price and willing to prepay a multi-month term for the lowest advertised rate.
Visit NexLifeThe verdict
Bayan Health takes it, leading the Cost-Efficiency Index 64 to 63. Bayan Health prices compounded semaglutide at $129 and tirzepatide at $149 a month, flat at every dose, and also sells oral drops, low-dose programs and orforglipron tablets — but ships two to three months at a time and bills for the whole protocol. NexLife still earns a C — Cost-first shoppers who want wanting a genuinely flat, dose-independent price and willing to prepay a multi-month term for the lowest advertised rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Bayan Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Bayan Health | NexLife |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 63/100 |
| Semaglutide / mo | $129.00/month billed monthly (standard injectable with vitamin B6; three months of medication ship at once) | $165/mo (all doses, compounded) |
| Tirzepatide / mo | $149.00/month billed monthly (standard injectable with vitamin B6; same three-month protocol) | $215/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $1,548 | $1,980 |
| Tirzepatide / yr (modeled) | $1,788 | $2,580 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #184 | #185 |
Bayan Health
64/100Where the value is
- Among the lowest published flat rates for either molecule, with the medication, the physician consultation and expedited shipping inside the figure
- "Same Flat Price. No Matter the Dose." is stated on the product pages, so the cost does not climb as a provider titrates
- Sells six GLP-1 routes at published prices — standard and low-dose injections, oral drops for both molecules — plus orforglipron tablets at $269 a month
The tradeoffs
- Medication ships two or three months at a time and the terms say the payment obligation covers the entire protocol dispensed, so a monthly figure is not a monthly commitment
- Opting out requires 15 days' notice before the next protocol cycle, while the FAQ says you can cancel at any time
NexLife
63/100Where the value is
- Flat pricing confirmed at every dose for both drugs — no per-mg escalation during titration, unlike most compounded competitors in this batch
- LegitScript certified with a named medical director (Adam Kennah, M.D.)
- States every batch undergoes independent third-party testing for potency, sterility, pH, and endotoxin levels
The tradeoffs
- The commonly advertised '$186/mo' tirzepatide headline requires a 12-month commitment; the true no-commitment month-to-month price is $215/mo — about 16% more
- No individual compounding pharmacy is named, only 'LegitScript-certified, NABP-accredited' pharmacies generically
Regulatory note: the FDA issued a warning letter to Nexlife Inc. dba Nexlife in June 2026. We still list and link to NexLife; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.